Haloperidol
CAS No. 52-86-8
Haloperidol( McN-JR 1625 | NSC 170973 | NSC 615296 | R 1625 )
Catalog No. M14873 CAS No. 52-86-8
Haloperidol has been found to be highlt potent neuroleptic by relieving nervous through the depression of nerve function.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 25MG | 29 | In Stock |
|
| 50MG | 37 | In Stock |
|
| 100MG | 47 | In Stock |
|
| 200MG | 60 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHaloperidol
-
NoteResearch use only, not for human use.
-
Brief DescriptionHaloperidol has been found to be highlt potent neuroleptic by relieving nervous through the depression of nerve function.
-
DescriptionHaloperidol has been found to be highlt potent neuroleptic by relieving nervous through the depression of nerve function. Besides, Haloperidol has shown about 50-fold potency than chiorpromazine, the other antipsychotic drug. Haloperidol has shown beneficial effects in the treatment of delusions and hallucinations. These effects are mainly achieved through blockage of dopamine receptors in the mesocortex and limbic system. (In Vivo):Haloperidol (1 mg) intra-arterially attenuates the dopamine-induced pancreatic secretion. Haloperidol (3 mg) completely inhibits the action of 10 μg of dopamine in the pancreas of the dogs. Haloperidol (10 mg/kg) as well as chlorpromazine (CPZ, 15 mg/kg) blocks mescaline-induced altered behavior within 7 to 10 minutes when injected into the mice 45 minutes after 50 mg/kg (2 μc) of mescaline. Haloperidol has no effect on mescaline disappearance.
-
In Vitro——
-
In VivoHaloperidol (1 mg) intra-arterially attenuates the dopamine-induced pancreatic secretion. Haloperidol (3 mg) completely inhibits the action of 10 μg of dopamine in the pancreas of the dogs. Haloperidol (10 mg/kg) as well as chlorpromazine (CPZ, 15 mg/kg) blocks mescaline-induced altered behavior within 7 to 10 minutes when injected into the mice 45 minutes after 50 mg/kg (2 μc) of mescaline. Haloperidol has no effect on mescaline disappearance.
-
SynonymsMcN-JR 1625 | NSC 170973 | NSC 615296 | R 1625
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT| Dopamine
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number52-86-8
-
Formula Weight375.87
-
Molecular FormulaC21H23ClFNO2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 8 mg/mL (21.28 mM); DMSO: 75 mg/mL (199.54 mM)
-
SMILESC1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
-
Chemical Name4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Cai G, et al. Mol Pharmacol. 1999 Nov;56(5):989-96.
molnova catalog
related products
-
Lorcaserin
Lorcaserin(APD356) is a selective full agonist of human 5-HT2C receptor with Ki of 15 nM.
-
Blonanserin
Blonanserin is a novel atypical antipsychotic agent with potent dopamine D2 and serotonin 5-HT2 receptors antagonist properties.
-
Eplivanserin
Eplivanserin is an effective and selective antagonist of 5-HT2A receptor with a Kd of 1.14 nM and an IC50 value of 5.8 nM in rat cortical membrane.
Cart
sales@molnova.com